4,259 HCA Healthcare, Inc. $HCA Shares Sold by Investment House LLC

Investment House LLC cut its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 47.1% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,789 shares of the company’s stock after selling 4,259 shares during the quarter. Investment House LLC’s holdings in HCA Healthcare were worth $2,044,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the company. BlackRock Inc. purchased a new position in HCA Healthcare in the second quarter valued at approximately $5,069,974,000. Wellington Management Group LLP grew its stake in HCA Healthcare by 20.5% during the second quarter. Wellington Management Group LLP now owns 4,707,473 shares of the company’s stock worth $1,835,397,000 after buying an additional 799,761 shares during the period. Darsana Capital Partners LP increased its position in shares of HCA Healthcare by 46.7% in the second quarter. Darsana Capital Partners LP now owns 1,100,000 shares of the company’s stock worth $428,879,000 after acquiring an additional 350,000 shares in the last quarter. Legal & General Group Plc acquired a new stake in shares of HCA Healthcare in the second quarter worth $410,992,000. Finally, Jupiter Topco LLC purchased a new position in shares of HCA Healthcare in the 2nd quarter valued at $371,138,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Key Headlines Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA is benefiting from a broader defensive rotation in which investors are emphasizing company quality and earnings resilience over traditional sector classifications. Defensive rotation: Quality over sector labels in healthcare, banks, and consumer staples
• Positive Sentiment: TD Cowen raised its price target for HCA to $460, signaling continued confidence in the hospital operator’s outlook and valuation. TD Cowen lifts target to USD 460
• Positive Sentiment: Cape Coral approved $31 million in incentives for a planned $300 million HCA hospital, supporting the company’s long-term expansion, market presence and future capacity in Florida. Cape Coral approves $31M in incentives for $300M HCA hospital
• Positive Sentiment: Analysts expect third-quarter results to benefit from higher admissions, occupancy and inpatient revenue. Investors are focused on whether these trends can support earnings ahead of HCA’s scheduled earnings call. Will HCA Healthcare’s Q3 Earnings Benefit From Higher Admissions?
• Neutral Sentiment: HCA opened a clinical training center in Gainesville, which could strengthen workforce development and staffing over time but is unlikely to materially affect near-term earnings. HCA Healthcare opens clinical training center in Gainesville
• Negative Sentiment: Higher operating costs and fewer outpatient surgeries could offset the benefit of stronger admissions, making the third-quarter earnings outlook mixed. Will HCA Healthcare’s Q3 Earnings Benefit From Higher Admissions?
• Negative Sentiment: HCA is disputing a state’s authority to enforce terms related to its Mission Health acquisition, creating potential legal, financial and reputational uncertainty. HCA disputes state’s authority to enforce purchase agreement

Wall Street Analysts Forecast Growth

HCA has been the topic of several recent research reports. Mizuho reduced their target price on shares of HCA Healthcare from $525.00 to $475.00 and set an “outperform” rating on the stock in a report on Tuesday, July 28th. BMO Capital Markets assumed coverage on HCA Healthcare in a research note on Tuesday, September 22nd. They set an “outperform” rating and a $495.00 price objective on the stock. Barclays decreased their target price on HCA Healthcare from $402.00 to $387.00 and set an “equal weight” rating for the company in a research report on Monday, July 27th. Oppenheimer lowered their target price on HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating for the company in a research note on Monday, July 27th. Finally, Cantor Fitzgerald reissued an “overweight” rating on shares of HCA Healthcare in a research report on Friday, October 2nd. Sixteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $467.61.

HCA Healthcare Price Performance

Shares of HCA stock opened at $467.00 on Friday. The firm has a market capitalization of $101.11 billion, a P/E ratio of 15.46, a P/E/G ratio of 1.55 and a beta of 1.10. The company’s fifty day moving average price is $430.28 and its two-hundred day moving average price is $418.61. HCA Healthcare, Inc. has a 12 month low of $353.99 and a 12 month high of $556.52.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. The business had revenue of $20.23 billion during the quarter, compared to the consensus estimate of $19.76 billion. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The business’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same quarter last year, the company earned $6.84 earnings per share. On average, sell-side analysts anticipate that HCA Healthcare, Inc. will post 29.45 EPS for the current year.

HCA Healthcare Company Profile

HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women’s and children’s services, behavioral health and outpatient care.

The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.